Topics include: psycadelic drugs and neuropsychiatry, psychotic phenomena: advances in understanding and treatment, the neuropsychiatry of Parkinson's disease and neuromodulation: state of the art in the UK
We have a fantastic line up of speakers to discuss core topics in neuropsychiatry including psychedelic drugs in neuropsychiatry, the neuropsychiatry of Parkinson’s disease, psychotic phenomena and state of the art neuromodulation. The meeting will cover the latest in scientific research as well as essential clinical practice updates. We are introducing new interdisciplinary clinical sessions and discussion of complex cases through psychiatry and neurology lenses. There will also be revamped poster sessions, the usual Lishman prize winners, and clinical updates with a twist.
The meeting will open with the BNPA Medal lecture, awarded to Andrew Lees, Professor of Neurology at University College London and the National Hospital for Neurology and Neurosurgery, Queen Square, in recognition of his enormous contribution to neurology, particularly in the field of Parkinson’s disease.
For the full program, please go to https://bnpa.org.uk/agm/. The early bird deadline is Jan 31.
